Immune Checkpoint Inhibitors and Anti-vascular Endothelial Growth Factor Antibody/Tyrosine Kinase Inhibitors With or Without HAIC for Unresectable HCC With Portal Vein Tumor Thrombosis

NCT06881433 · clinicaltrials.gov ↗
COMPLETED
Status
1649
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

Zhongda Hospital